BlackRock’s iSpecimen ISPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$444 Hold
71
﹤0.01% 5576
2025
Q4
$735 Hold
71
﹤0.01% 5432
2025
Q3
$3.65K Hold
71
﹤0.01% 5290
2025
Q2
$2.77K Hold
71
﹤0.01% 5307
2025
Q1
$3K Hold
71
﹤0.01% 5285
2024
Q4
$7.51K Hold
71
﹤0.01% 5194
2024
Q3
$13.3K Hold
71
﹤0.01% 4975
2024
Q2
$17.5K Hold
71
﹤0.01% 5022
2024
Q1
$13.1K Hold
71
﹤0.01% 5062
2023
Q4
$28.4K Hold
71
﹤0.01% 5041
2023
Q3
$35.2K Hold
71
﹤0.01% 5066
2023
Q2
$81.1K Hold
71
﹤0.01% 4982
2023
Q1
$76K Hold
71
﹤0.01% 5035
2022
Q4
$78K Hold
71
﹤0.01% 5117
2022
Q3
$94K Hold
71
﹤0.01% 5193
2022
Q2
$124K Sell
71
-18
-20% -$44.1K ﹤0.01% 5172
2022
Q1
$382K Buy
89
+80
+889% +$313K ﹤0.01% 4948
2021
Q4
$56K Buy
9
+1
+13% +$7.18K ﹤0.01% 5383
2021
Q3
$35K Buy
+8
New +$38.8K ﹤0.01% 5332

Other funds holding ISPC

BlackRock's ISPC Position: Q1 2026 in Review

BlackRock held its iSpecimen (ISPC) position steady in Q1 2026 at 71 shares worth $444. The position accounts for ﹤0.01% of the portfolio, ranked #5576.

BlackRock first reported a position in ISPC in Q3 2021 and has held it in 19 quarters since. The position peaked at $382K in Q1 2022. 9 funds tracked by Wall St. Rank hold ISPC as of Q1 2026.

  • BlackRock held 71 shares of iSpecimen worth $444 as of Q1 2026.
  • BlackRock left its iSpecimen share count unchanged in Q1 2026.
  • iSpecimen made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5576 holding.
  • BlackRock first reported a position in iSpecimen in Q3 2021 and has held it in 19 quarters since.
  • BlackRock's iSpecimen position peaked at $382K in Q1 2022.
  • 9 funds tracked by Wall St. Rank held iSpecimen as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.